Author:
Sharain Korosh,AbouEzzeddine Omar F.,Homb Andrew,Chareonthaitawee Panithaya
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging
Reference6 articles.
1. Christopoulos G, Jouni H, Acharya GA, et al. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol. J Nucl Cardiol 2019. https://doi.org/10.1007/s12350-019-01746-4.
2. Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 2017;58:1341-53.
3. Bois JP, Chareonthaitawee P. Patient page-sarcoidosis imaging. J Nucl Cardiol 2019;26:222-6.
4. Manabe O, Ohira H, Yoshinaga K, et al. Qualitative and quantitative assessments of cardiac sarcoidosis using 18F-FDG PET. Focus issue: Cardiac sarcoidosis—from the CME session at 63rd SNMMI annual meeting—review article. Ann Nucl Cardiol 2017;3:117-20.
5. Varghese M, Smiley D, Bellumkonda L, et al. Quantiative interpretation of FDG PET for cardiac sarcoidosis reclassififes visually interpreted exams and potentially impacts downstream interventions. Sarcoidosis Vasculitis Diffuse Lung Dis 2018;35:342-53.